25.10.2012
To the attention of Marketing Authorisation Holders concerning trimetadizine-containing medicinal products
The NAMMD hereby emphasises the mandatory character of compliance with the following conditions for marketing authorisations of trimetazidine-containing medicinal products, as provided in the European Commission Decision for completion of Art. 31 referral procedure.
download document …